Slingshot members are tracking this event:

Allergan (AGN) Announces FDA Approval Of RHOFADE (Oxymetazoline Hydrochloride) Cream, 1% For The Topical Treatment Of Persistent Facial Erythema Associated With Rosacea In Adults

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
AGN Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 19, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Rhofade, Oxymetazoline Hydrochloride, Persistent Facial Erythema, Rosacea